Factors associated with myocarditis in patients with cancer treated with immune checkpoint inhibitors

被引：0
|
作者：
Izadi, Zara
Zhang, Yan
Lou, Youbei
Dreyfus, Brian
Plautz, Greg
Wolf, Robert
Cooper, Leslie
机构：
[1] Bristol Myers Squibb, Princeton, NJ USA
[2] Mayo Clin, Jacksonville, FL 32224 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e14674
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Genomic markers associated with hyperprogression in patients with lung cancer treated with immune checkpoint inhibitors.
    Tadesse, Eyob Ale
    Heslin, Kayla
    Hendawi, Mohamed
    Peterson, Luke
    Wolf, Frank M.
    Brown, Thomas D.
    Thompson, Michael A.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [22] Factors associated with radiation necrosis and intracranial control in patients treated with immune checkpoint inhibitors and stereotactic radiotherapy
    Hall, Jacob
    Lui, Kevin
    Tan, Xianming
    Shumway, John
    Collichio, Frances
    Moschos, Stergios
    Sengupta, Soma
    Chaudhary, Rekha
    Quinsey, Carolyn
    Jaikumar, Sivakumar
    Forbes, Jonathan
    Andaluz, Norberto
    Zuccarello, Mario
    Struve, Timothy
    Vatner, Ralph
    Pater, Luke
    Breneman, John
    Weiner, Ashley
    Wang, Kyle
    Shen, Colette
    RADIOTHERAPY AND ONCOLOGY, 2023, 189
  • [23] ICU admission for solid cancer patients treated with immune checkpoint inhibitors
    Anne-Claire Toffart
    Anne-Pascale Meert
    Florent Wallet
    Aude Gibelin
    Olivier Guisset
    Frédéric Gonzalez
    Amélie Seguin
    Achille Kouatchet
    Myriam Delaunay
    Didier Debieuvre
    Boris Duchemann
    Gaëlle Rousseau-Bussac
    Martine Nyunga
    David Grimaldi
    Albrice Levrat
    Elie Azoulay
    Virginie Lemiale
    Annals of Intensive Care, 13
  • [24] Hyperprogressive disease in patients with advanced cancer treated with immune checkpoint inhibitors
    Sen, Gulin Alkan
    Oztas, Nihan Senturk
    Degerli, Ezgi
    Guliyev, Murad
    Can, Guenay
    Turna, Hande
    Ozguroglu, Mustafa
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2024, 26 (12): : 3264 - 3271
  • [25] TRANSCRIPTOMIC CHANGES IN CANCER PATIENTS TREATED WITH IMMUNE-CHECKPOINT INHIBITORS
    Shek, Dmitrii
    Gao, Bo
    Lai, Joey
    Yoon, Won-Hee
    Moujaber, Tania
    Nagrial, Adnan
    Carlino, Matteo
    Read, Scott
    Ahlenstiel, Golo
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A552 - A552
  • [26] Blood pressure surveillance in cancer patients treated with immune checkpoint inhibitors
    Tan, Sean
    Spear, Ella
    Sane, Nikhita
    Nelson, Adam J.
    Nerlekar, Nitesh
    Segelov, Eva
    Nicholls, Stephen J.
    JOURNAL OF HUMAN HYPERTENSION, 2023, 37 (11) : 1043 - 1046
  • [27] ICU admission for solid cancer patients treated with immune checkpoint inhibitors
    Toffart, Anne-Claire
    Meert, Anne-Pascale
    Wallet, Florent
    Gibelin, Aude
    Guisset, Olivier
    Gonzalez, Frederic
    Seguin, Amelie
    Kouatchet, Achille
    Delaunay, Myriam
    Debieuvre, Didier
    Duchemann, Boris
    Rousseau-Bussac, Gaelle
    Nyunga, Martine
    Grimaldi, David
    Levrat, Albrice
    Azoulay, Elie
    Lemiale, Virginie
    ANNALS OF INTENSIVE CARE, 2023, 13 (01)
  • [28] Thromboembolism in Patients with Metastatic Urothelial Cancer Treated with Immune Checkpoint Inhibitors
    Iris Y. Sheng
    Shilpa Gupta
    Chandana A. Reddy
    Dana Angelini
    Pauline Funchain
    Tamara A. Sussman
    Joseph Sleiman
    Moshe C. Ornstein
    Keith McCrae
    Alok A. Khorana
    Targeted Oncology, 2022, 17 : 563 - 569
  • [29] Autoimmune phenomena and disease in cancer patients treated with immune checkpoint inhibitors
    Tocut, Milena
    Brenner, Ronen
    Zandman-Goddard, Gisele
    AUTOIMMUNITY REVIEWS, 2018, 17 (06) : 610 - 616
  • [30] Thromboembolism in Patients with Metastatic Urothelial Cancer Treated with Immune Checkpoint Inhibitors
    Sheng, Iris Y.
    Gupta, Shilpa
    Reddy, Chandana A.
    Angelini, Dana
    Funchain, Pauline
    Sussman, Tamara A.
    Sleiman, Joseph
    Ornstein, Moshe C.
    McCrae, Keith
    Khorana, Alok A.
    TARGETED ONCOLOGY, 2022, 17 (05) : 563 - 569
12345